Abstract:Objective To summarize the diagnosis,treatment and prognosis of pancreatic cystic neoplasms (PCN) in our center as to provide some useful information for the diagnosis and treatment of PCN.Methods A retrospective analysis of patients with PCN in Nanjing Drum Tower Hospital from January 2005 to October 2016 was conducted.Clinical characteristics,EUS features,treatment and prognosis of each type of PCN were evaluated.Results In this study,222 PCN patients were collected including 94 patients of intraductal papillary mucinous neoplasm (IPMN),58 patients of mucinous cystic neoplasm (MCN),43 patients of serous cystic neoplasm (SCN) and 27 patients of solid pseudopaillary neoplasm (SPN).Among PCN patients,the male/female ratio was 1:1.55 and the mean age was 56.0± 15.7 years.Moreover,142 (64.0％,142/222) PCN patients had symptoms or signs,of which the most common symptom was abdominal pain (47.3％,105/222).The postoperative pathological results of 7 IPMN patients (16.3％,7/43) and 5 MCN patients (9.1％,5/55) were malignant (invasive carcinoma or high-grade dysplasia),while those of SCN or MCN patients were all benign (P=0.027).For those patients under surveillance,there were 4 IPMN patients (8.3％,4/48) and 2 SPN patients (66.7％,2/3) progressing into cancer.The 5-year overall survival rate of 188 PCN patients with complete follow-up data was 86.0％.After surgery the 5-year overall survival rates of 124 PCN patients was 90.0％.The 5-year overall survival rates of SCN,MCN and SPN patients were 100.0％,92.1％ and 93.8％,respectively,while that of IPMN was only 74.0％ (P =0.003).Conclusion PCN are found mostly in middle-aged females and most of the patients have symptoms or signs,of which abdominal pain is the most common symptom.IPMN,MCN and SPN have risks of progressing into malignancy.Thus,patients of IPMNs,MCNs or SPNs should receive surgery when it is appropriate;However,SCN patients should be put under surveillance.The prognosis of PCN after surgery varies a lot,among which IPMN shows the worst prognosis while other types of PCN all show comparatively good results.

Low-Pass Genomic Sequencing Reveals Novel Subtypes of Pancreatic Cystic Neoplasms

The “extracapsular Cystic” Sign in Pancreatic Serous Cystic Neoplasms: A Clinicopathologic Study of 177 Patients with Cystic Pancreatic Lesions

Pancreatic cystic neoplasms: current and future approaches to identify patients at risk

Pancreas Integrated Chromosomal Instability and Tumor Microbiome Redefined Prognosis-Related Subtypes of Pancreatic Cancer

Preoperative diagnosis of the malignancy for pancreatic cystic neoplasms

Integrated targeted metabolomic and lipidomic analysis: A novel approach to classifying early cystic precursors to invasive pancreatic cancer

Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study

AB086. P058. Current Status of Pancreatic Cystic Neoplasm: Diagnosis and Treatment a Multi-Institution Retrospective Study in China

A novel distinguishing system for the diagnosis of malignant pancreatic cystic neoplasm.

Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer

Differential Diagnosis of Pancreatic Cystic Neoplasms Through a Radiomics-Assisted System

Clinical characteristics and survival prediction of surgical patients with invasive pancreatic cystic neoplasm: a large retrospective study over two decades

Diagnosis and treatment of pancreatic cystic neoplasms:a report of 222 cases

A Series of 64 Cases of Pancreatic Cystic Neoplasia from an Institutional Study of China

Pancreatic cystic neoplasms: a review of preoperative diagnosis and management

Cystic Neoplasms of the Pancreas: Differential Diagnosis and Radiology Correlation

Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations

Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis

Surgical Resection and Outcome of Pancreatic Cystic Neoplasms in China: Analysis of a 16-Year Experience from a Single High-Volume Academic Institution

Preoperative Ultrasound Combined with Routine Blood Tests in Predicting the Malignant Risk of Pancreatic Cystic Neoplasms

Differentiating Pancreatic Ductal Adenocarcinoma from Pancreatic Serous Cystadenoma, Mucinous Cystadenoma, and a Pseudocyst with Detailed Analysis of Cystic Features on CT Scans: a Preliminary Study